<DOC>
	<DOCNO>NCT01621256</DOCNO>
	<brief_summary>The purpose study determine whether ancrod effective safe treatment sudden sensorineural hearing loss ( SSHL ) .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability Ancrod Patients With Sudden Hearing Loss</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Ear Diseases</mesh_term>
	<mesh_term>Hearing Disorders</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ancrod</mesh_term>
	<criteria>Unilateral idiopathic sudden sensorineural hearing loss â‰¥30 dB Symmetric hear prior onset SSHL Enrollment accomplish within 7 day SSHL onset Bilateral SSHL Incomplete recovery previous SSHL Previously exist , know retrocochlear hearing loss Any history ear operation local inflammatory disease past one year History blunt penetrate ear trauma , head trauma , barotrauma , acoustic trauma immediately precede SSHL History Meniere 's disease , autoimmune hearing loss , radiationinduced hearing loss , endolymphatic hydrops . Treatment steroid reason within precede 30 day . Body weight &gt; 140 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>